A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces

被引:0
作者
Chen, Jun [1 ]
Yang, Jingwen [1 ]
Shen, Dayong [1 ]
Wang, Xi [1 ]
Lin, Zihao [1 ]
Chen, Hao [1 ]
Cui, Guiyun [1 ]
Zhang, Zuohui [1 ,2 ]
机构
[1] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou 221006, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu 22106, Peoples R China
基金
加拿大健康研究院;
关键词
Alzheimer's disease; mild cognitive impairment; nomogram; perivascular space; SMALL-VESSEL DISEASE; BIOMARKERS; RISK; MCI;
D O I
10.3233/JAD-240523
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Mild cognitive impairment (MCI) is a heterogeneous condition that can precede various forms of dementia, including Alzheimer's disease (AD). Identifying MCI subjects who are at high risk of progressing to AD is of major clinical relevance. Enlarged perivascular spaces (EPVS) on MRI are linked to cognitive decline, but their predictive value for MCI to AD progression is unclear. Objective: This study aims to assess the predictive value of EPVS for MCI to AD progression and develop a predictive model combining EPVS grading with clinical and laboratory data to estimate conversion risk. Methods: We analyzed 358 patients with MCI from the ADNI database, consisting of 177 MCI-AD converters and 181 non-converters. The data collected included demographic information, imaging data (including perivascular spaces grade), clinical assessments, and laboratory test results. Variable selection was conducted using the Least Absolute Shrinkage and Selection Operator (LASSO) method, followed by logistic regression to develop predictive model. Results: In the univariate logistic regression analysis, both moderate (OR = 5.54, 95% CI [3.04-10.18]) and severe (OR =25.04, 95% CI [10.07-62.23]) enlargements of the centrum semiovale perivascular space (CSO-PVS) were found to be strong predictors of disease progression. LASSO analyses yielded 12 variables, refined to six in the final model: APOE4 genotype, ADAS11 score, CSO-PVS grade, and volumes of entorhinal, fusiform, and midtemporal regions, with an AUC of 0.956 in the training and 0.912 in the validation cohort. Conclusions: Our predictive model, emphasizing EPVS assessment, provides clinicians with a practical tool for early detection and management of AD risk in MCI patients.
引用
收藏
页码:159 / 173
页数:15
相关论文
共 50 条
  • [41] Physical Activity and Mild Cognitive Impairment and Alzheimer's Disease
    Lautenschlager, Nicola T.
    Cox, Kay
    Kurz, Alexander F.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (05) : 352 - 358
  • [42] Predicting conversion from mild cognitive impairment to Alzheimer's disease with multimodal latent factors
    Chang, Minyu
    Brainerd, C. J.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2022, 44 (04) : 316 - 335
  • [43] Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease
    Persson, Karin
    Barca, Maria Lage
    Eldholm, Rannveig Sakshaug
    Cavallin, Lena
    Benth, Jurate Saltyte
    Selbaek, Geir
    Braekhus, Anne
    Saltvedt, Ingvild
    Engedal, Knut
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2017, 44 (1-2) : 12 - 24
  • [44] Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
    Guidi, I
    Galimberti, D
    Lonati, S
    Novembrino, C
    Bamonti, F
    Tiriticco, M
    Fenoglio, C
    Venturelli, E
    Baron, P
    Bresolin, N
    Scarpini, E
    NEUROBIOLOGY OF AGING, 2006, 27 (02) : 262 - 269
  • [45] Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
    Kesler, Anat
    Vakhapova, Veronika
    Korczyn, Amos D.
    Naftaliev, Elvira
    Neudorfer, Meira
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 523 - 526
  • [46] Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment
    Musaeus, Christian Sandoe
    Nielsen, Malene Schjonning
    Hogh, Peter
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [47] Injury Markers but not Amyloid Markers are Associated with Rapid Progression from Mild Cognitive Impairment to Dementia in Alzheimer's Disease
    van Rossum, Ineke A.
    Visser, Pieter Jelle
    Knol, Dirk L.
    van der Flier, Wiesje M.
    Teunissen, Charlotte E.
    Barkhof, Frederik
    Blankenstein, Marinus A.
    Scheltens, Philip
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (02) : 319 - 327
  • [48] Longitudinal survival analysis and two-group comparison for predicting the progression of mild cognitive impairment to Alzheimer's disease
    Platero, Carlos
    Tobar, M. Carmen
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 341
  • [49] Predicting Alzheimer's Progression in Mild Cognitive Impairment: Longitudinal MRI with HMMs and SVM Classifiers
    Ajabani, Deep Himmatbhai
    INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS, 2023, 14 (12) : 10 - 25
  • [50] Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease
    Thomas, Alan J.
    Hamilton, Calum A.
    Barker, Sally
    Durcan, Rory
    Lawley, Sarah
    Barnett, Nicola
    Firbank, Michael
    Roberts, Gemma
    Allan, Louise M.
    O'Brien, John
    Taylor, John-Paul
    Donaghy, Paul C.
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (06) : 585 - 592